edaravone has been researched along with Epilepsy in 3 studies
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
Excerpt | Relevance | Reference |
---|---|---|
"The effects of edaravone against pentylenetetrazole (PTZ)-induced epilepsy in male albino rats were investigated." | 7.91 | Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II. ( Liu, LM; Lu, Y; Wang, N; Wang, WP, 2019) |
"The effects of edaravone against pentylenetetrazole (PTZ)-induced epilepsy in male albino rats were investigated." | 3.91 | Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II. ( Liu, LM; Lu, Y; Wang, N; Wang, WP, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Z | 1 |
Yang, C | 1 |
Meng, X | 1 |
Li, Z | 1 |
Lv, C | 1 |
Cao, P | 1 |
Liu, LM | 1 |
Wang, N | 1 |
Lu, Y | 1 |
Wang, WP | 1 |
Miyamoto, R | 1 |
Shimakawa, S | 1 |
Suzuki, S | 1 |
Ogihara, T | 1 |
Tamai, H | 1 |
3 other studies available for edaravone and Epilepsy
Article | Year |
---|---|
Neuroprotection of edaravone on the hippocampus of kainate-induced epilepsy rats through Nrf2/HO-1 pathway.
Topics: Animals; Edaravone; Epilepsy; Free Radical Scavengers; Heme Oxygenase-1; Hippocampus; Kainic Acid; M | 2018 |
Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II.
Topics: Animals; Antioxidants; Brain; Convulsants; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation | 2019 |
Edaravone prevents kainic acid-induced neuronal death.
Topics: Aldehydes; Animals; Antipyrine; Brain; Cell Death; Disease Models, Animal; Down-Regulation; Edaravon | 2008 |